OSAKA University Venture Capital

Co-investorsDBJ Capital

A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments.

BiotechDeep TechHealthtechMedical DevicesMatsumoto, JP

Yozo Nakazawa(Founder & Director; Professor, Department of Pediatrics, Shinshu University)Shigeki Yagyu(Representative Director (CEO))Takuji Achiha(Chief Development Officer)Kiyohito Tani(Chief Operating Officer)

Co-investorsDelight VenturesNippon Venture Capital

A-wave develops medical devices and related software/hardware products for healthcare applications.

AI & Machine LearningHealthtechMedical Devices大阪市, JP

Co-investorsGlobal Brain

AIBTRUST is a University of Osaka-originated venture company based in Japan working in the artificial intelligence field.

AI & Machine LearningData & InfrastructureDigital HealthTokyo, JP

森岡 康一(代表取締役 (Representative Director))

Bioworks develops PlaX, a plant-based fiber intended as an alternative to petroleum-derived synthetic fibers, aimed at making the apparel industry more sustainable.

BiotechCircular EconomyNew Materials未記載, JP

今井 行弘(取締役会長 (Founder))坂本 孝治(代表取締役社長 CEO)寺田 貴彦(取締役常務執行役員 CTO)

Co-investorsGOLDWIN VENTURE PARTNERS

Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities.

BiotechDeep TechHealthtechMedical Devices

Nobuyuki Arakawa(Co-founder & Representative Director, President & CEO)Motoo Watanabe(Co-founder / Advisor (former Chairman & CSO))Hiromitsu Nakauchi(Co-founder)Masatoshi Sakurai(Co-founder)Yusuke Inoue(Director, COO & CFO)Asako Uchiyama(Director, CDO (Chief Development Officer))

Co-investorsKobe University Capital

Crimson Technology is a Japanese company involved in music-related technology, including audio and AI music, with affiliations to Japanese music electronics and metadata industry bodies.

AI & Machine LearningCreator EconomyMedia & EntertainmentTokyo, JP

Kazuo Higa(代表取締役 (Representative Director))

EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality.

CleantechDeep TechEnergyKyoto, JP

Kazuki Matsuo(代表取締役社長 (President & CEO))

Co-investorsDelight VenturesMiyako CapitalMPowerShizuoka Capital

GAIA BioMedicine (株式会社ガイアバイオメディシン) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University.

BiotechHealthtechMedical DevicesFukuoka, JP

Yoshikazu Yonemitsu(Founder)Kazuyuki Kuramori(Representative Director, President & CEO)Yui Harada(Director & CTO)Daisuke Ara(Director & CFO)

Co-investorsJIC Venture Growth InvestmentsUntroD Capital

HOIST is an Osaka University-derived biotech venture developing anti-cancer drugs, focusing on novel modalities and mechanisms of action for cancers that lack sufficient treatments.

BiotechDigital HealthHealthtechMedical DevicesWakayama, JP

柿沼千早(代表取締役 (CEO))

HULIX is an Osaka University spinout building 3D spatial AI that uses LiDAR, SLAM, 3D point cloud analysis, and digital twin technology to convert real-world spaces into AI-usable data.

AI & Machine LearningData & InfrastructureDeep TechIoTSuita, JP

Mitsuo Moriya(Representative Director & CEO)

BoardHiromi Yamaguchi(Director)

Co-investorsKobe University Capital

J-Tec develops, manufactures, and sells high-precision X-ray mirrors ("OsakaMirror") and other optical elements based on ultra-precision machining and metrology, along with ultra-precision polishing equipment for Si, SiC, diamond, and ceramic wafers.

Advanced ManufacturingDeep TechHardwareSemiconductorsOsaka, JP

JEPLAN is a Japanese group focused on recycling and circular economy, working with domestic and international partners under the mission of "circulating all things." It aims to advance a circular economy through recycling technologies and operations across its business sites and factories.

Circular EconomyCleantechClimate TechNew MaterialsTokyo, JP

髙尾 正樹(代表取締役 執行役員社長 (President & CEO))

Co-investorsGOLDWIN VENTURE PARTNERSShizuoka CapitalUntroD CapitalUniversal Materials Incubator

KOTAI Biotechnologies develops an immune AI platform and big data analysis pipeline that combines artificial intelligence with immunology for antibody and immune-repertoire analysis.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMinoh, JP

山下 和男(共同創業者・代表取締役 (Co-founder & CEO))Kazuo Yamashita(Co-founder & CEO)

LQUOM develops long-distance quantum communication technology and quantum repeaters to enable theoretically unhackable quantum internet for sectors including finance, telemedicine, and defense.

CybersecurityDeep TechQuantum ComputingYokohama, JP

Kazuya Niizeki(Co-founder & CEO)Tomoyuki Horikiri(Co-founder & CSO, Director)

Co-investorsMPower

Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development.

BiotechHealthtechMedical Devices

Co-investorsBeyond Next VenturesF-Prime CapitalSony Ventures Corporation

MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesKyoto, JP

Kazuo Miyazaki(代表取締役CEO (Representative Director & CEO))Kazuhisa Fushihara(取締役CFO (Director & CFO))

BoardYasuhiro Natsume(取締役 (Director))

Co-investorsKobe University CapitalUntroD Capital

MyImmune develops AI that analyzes adaptive immune repertoire data to identify drug targets, predict patient responses to immunotherapies, and build biomarkers and companion diagnostics.

AI & Machine LearningBiotechDigital Health

PaMeLa develops compact, low-burden medical devices that use artificial intelligence to objectively measure and visualize pain, addressing the reliance on patients' subjective self-reporting.

AI & Machine LearningDigital HealthHealthtechMedical DevicesOsaka, JP

後藤 宏明(代表取締役 (Representative Director))

Co-investorsUniversal Materials Incubator

Co-investorsUniversal Materials Incubator

Co-investorsKeio Innovation Initiative

Red Arrow Therapeutics develops cancer therapies using a proprietary nanopolymer drug-delivery system for programmable encapsulation and release of biologics such as peptides, antibodies, and proteins.

BiotechHealthtechMedical DevicesCambridge, US

Horacio Cabral(Scientific Founder / Technology Pioneer)Philipp Steiner(Chief Scientific Officer (CSO))

Co-investorsBeyond Next VenturesUTEC

Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials.

BiotechDigital HealthHealthtechMedical DevicesTokyo, JP

Dr. Rajendra S. Apte(Paul A. Cibis Distinguished Professor; Vice Chair of Innovation and Translation; Founder)

Co-investorsAstellas Venture Management LLCDBJ CapitalJIC Venture Growth InvestmentsKyoto University Innovation CapitalNippon Venture CapitalRemiges Ventures, Inc.+3 more

Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders.

BiotechDeep TechMedical DevicesSuita, JP

Shinsei Omori(Representative Director, President & CEO)

Company that produces complex ceramic components using a stereolithography (slurry-based) 3D printing process, in which ceramic powder is mixed with UV-curable resin, shaped layer by layer with a UV laser, then debinded and sintered.

Advanced ManufacturingHardwareNew MaterialsKusatsu, JP

Tadakatsu Asano(Representative Director & President)

TCN Prime develops medical devices for cardiovascular applications, including innovative catheter systems for treating aortic stenosis and ECMO support.

Deep TechHealthtechMedical DevicesTokyo, JP

小西明英(CEO / Representative Director)岩崎正道(Director / CMO)八木隆浩(Director / CTO)三池信也(Director / CFO)

Co-investorsKobe University Capital

Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.

BiotechDigital Health

Co-investorsGlobal BrainKobe University Capital

IMMUNOSENS manufactures in vitro diagnostic pharmaceuticals and third-class medical devices for clinical diagnostic purposes.

BiotechHealthtechMedical Devices

Co-investorsGlobal Brain

Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring.

BiotechDeep TechHealthtechMedical DevicesOsaka, JP

Toshikazu Nakamura安達喜一

Co-investorsDBJ Capital

J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases.

BiotechDigital HealthHealthtechMedical DevicesTokyo, JP

𠮷武 益広(代表取締役社長 (Representative Director & President))藤本 裕(取締役CFO)山本 寛(取締役CBO)

Co-investorsF-Prime CapitalNewton BiocapitalOita Venture CapitalSeibu Shinkin CapitalUntroD Capital

ThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology.

AI & Machine LearningBiotechDeep TechMedical DevicesRedwood City, US

Waichiro(Co-founder & CEO)Sadao(Co-founder & CSO)Issei(Co-founder & Senior Scientific Advisor)Ryoichi(Co-founder)

Co-investorsGlobal BrainUntroD Capital

NexFi Technology Inc. develops, manufactures, and sells high-voltage power equipment using next-generation SiC (silicon carbide) power devices.

CleantechDeep TechEnergyHardwareSemiconductorsOsaka, JP

Takashi Nakamura(代表取締役社長 (President & CEO))

Co-investorsTEL Venture Capital, Inc.

A company developing microwave-based chemical processing technology to improve energy efficiency and reduce carbon emissions in the chemical manufacturing industry.

Advanced ManufacturingCleantechClimate TechDeep TechNew Materials吹田市, JP

塚原 保徳(代表取締役CSO（最高科学責任者）)Iwao Yoshino(Representative Director CEO)Yasunori Tsukahara(Representative Director CSO)吉野 巌(代表取締役社長CEO)

Co-investorsINCJ, Ltd.DBJ CapitalSMBC Venture Capital

3DC develops Graphene MesoSponge (GMS), a three-dimensional carbon material invented at Tohoku University, and advanced electrode manufacturing technologies to improve battery performance.

CleantechDeep TechNew Materials

Takuma Kuroda(Founder)in

Co-investorsSony Ventures CorporationUntroD Capital